By contrast, distinct effects of knocking out LKB1 and AMPK can be seen in the case of the liver, in which loss of LKB1 causes marked hyperglycemia, whereas mice with liver-specific loss of both AMPK catalytic subunits are normoglycemic. The gene discussed is PRKAA1; the disease is Hyperglycemia.